Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers

Recruiting now · Not applicable

Conditions studied: Blood Self-Collection for Clinical Diagnostic Assessments

In brief

This study aims to assess the effectiveness and reliability of the Tasso+ capillary blood self-collection device in the clinical diagnostic assessment of various biomarkers. The study will collect blood specimens using both the Tasso+ self-collection device and traditional venipuncture. The biomarker analysis results from both specimen types will be compared for correlation.

Key facts

Study ID

NCT05852925

Run by

American Research Labs

People needed

2500

Starts

2023-07-25

Expected to finish

2026-07-01

Last updated by the study team

2025-08-29

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• To participate in this study, an individual must meet all the following criteria:
• Age: Participants must be 13 years of age or older.
• Medical history: There may be no specific medical history requirements for inclusion, although participants may need to meet certain general health criteria.
• Sample type: Participants must be willing and able to provide the human specimens needed for the study, such as blood, urine, or saliva.
• Ability to provide consent: Participants must have the ability to provide informed consent to participate in the study, either on their own behalf if they are legally able to do so, or with the consent of a parent or guardian if they are under 18 years of age.
• Language proficiency: Participants must be able to read and understand the language used in the study materials, such as informed consent forms and instructions for specimen collection.

You may not qualify if…

• Participation in this study will be excluded for individuals who meet the following criterion:
• Blind or visually impaired: Participants who are unable to see or have significant visual impairment that would make it difficult for them to participate in the study.
• Decisionally impaired: Participants who are unable to provide informed consent due to cognitive impairment, developmental disability, or other mental health conditions that affect decision-making capacity.
• Educationally disadvantaged: Participants who lack the education or literacy skills required to understand the study procedures or provide informed consent.
• Hospitalized: Participants who are currently hospitalized, as they may not be able to participate in the study due to their medical condition or limited mobility.
• Prisoners: Participants who are incarcerated in correctional facilities, as their participation may raise ethical concerns or require additional regulatory approvals.
• Terminally ill: Participants who have a terminal illness or life-limiting condition that may affect the study results or pose additional risks to their health.
• Excluding individuals with these characteristics from the study is intended to ensure their safety and well-being and to maintain the integrity of the study results.

Where it is running

• American Research Labs — Atlantis, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.